Company: NDRA
Filing Date: 2025-04-07
Form Type: 10-K/A
Source: 0001654954-25-003937
Chunk: 2

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-04-07
Form: 10-K/A
Chunk 2
---
 of the registrant, as of June 30, 2024, was approximately $ based on the closing sales price of the common stock as reported on the Nasdaq Capital Market on June 28, 2024.

As of March 24, 2025, there were shares of the registrant’s common stock outstanding.

<div align='center'>DOCUMENTS INCORPORATED BY REFERENCE</div>

None.

<div align='center'>EXPLANATORY NOTE</div>

This Amendment No. 1 (the “Amendment No. 1”) to the Annual Report on Form 10-K of ENDRA Life Sciences Inc. (the “Company”) for the year ended December 31, 2024, originally filed with the Securities and Exchange Commission on March 31, 2025 (the “Original Report”), is being filed solely to correct a typographical error in the report of RBSM LLP, the Company’s independent auditor for the fiscal year ended December 31, 2024 (the “Auditor’s Report”), relating to the date of the Auditor’s Report and RBSM LLP’s PCAOB ID number, which were inadvertently omitted in the EDGAR preparation process. Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended, the entire text of Item 8 of the Form 10-K is repeated in this Amendment No. 1. However, there have been no changes to the text of such item other than the addition of the date of the Auditor’s Report and RBSM LLP’s PCAOB ID number.

The Company is including in this Amendment No. 1 currently dated certifications from its Chief Executive Officer and Chief Financial Officer as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 as Exhibits 31.1 and 31.2 and Exhibit 32.1, respectively. As a result, Item 15 “Exhibits and Financial Statement Schedules” has also been modified.

Except as expressly set forth above, this Amendment No. 1 speaks as of the filing date of the Original Report, and does not reflect events that may have occurred subsequent to that date, nor does it modify or update in any way disclosure made in the Original Report.

<div align='center'>ENDRA LIFE SCIENCES INC.

TABLE OF CONTENTS</div>

|          |                                               |     | Page |
| PART II  |                                               |     |      |
| Item